Edmond de Rothschild leads SFr 25m GlycoVaxyn funding round
Edmond de Rothschild Investment Partners has led a CHF25m (€17m) second round of funding for Swiss pharma company GlycoVaxyn.
Edmond de Rothschild Investment Partners has led a CHF25m (€17m) second round of funding for Swiss pharma company GlycoVaxyn.